https://ph-ksp.com/whats-new-in-pulmonary-hypertension-on-the-knowledge-sharing-platform-in-july-2026/ 2026-07-30T11:13:19Z PULMONARY HYPERTENSION en What's new in Pulmonary Hypertension on the Knowledge Sharing Platform in July 2026 2026-07-30T10:22:09Z Blog https://ph-ksp.com/the-pulmonary-vascular-research-institute-launches-the-global-ph-consult-a-new-free-online-service-for-clinicians/ 2026-07-30T08:58:34Z PULMONARY HYPERTENSION en The Pulmonary Vascular Research Institute launches the Global PH Consult, a new, free, online service for clinicians which aims to support more equitable access to pulmonary hypertension case discussion and shared learning 2026-07-30T08:55:45Z Blog https://ph-ksp.com/long-term-efficacy-and-safety-of-rehabilitation-in-patients-with-pulmonary-arterial-hypertension-the-french-fonce-htap-randomized-controlled-trial-annals-of-american-thoracic-society-july-20-2026/ 2026-07-30T08:48:08Z PULMONARY HYPERTENSION en Long-term efficacy and safety of rehabilitation in patients with pulmonary arterial hypertension: the French FONCE-HTAP randomized controlled trial, Annals of American Thoracic Society, July 20, 2026 2026-07-30T08:48:06Z Blog https://ph-ksp.com/caring-for-the-whole-person-a-conversation-with-susanne-mcdevitt-critical-care-nurse-practitioner-with-the-pulmonary-hypertension-ph-program-university-of-michigan-ann-arbor/ 2026-07-30T08:40:04Z PULMONARY HYPERTENSION en Caring for the whole person, a conversation with Susanne McDevitt, critical care nurse practitioner with the Pulmonary Hypertension (PH) Program, University of Michigan, Ann Arbor 2026-07-30T08:40:02Z Blog https://ph-ksp.com/quality-of-life-outcomes-in-patients-with-pulmonary-hypertension-receiving-prostacyclin-therapy-impact-of-anxiety-depression-sociodemographic-characteristics-and-treatment-related-factors-turkish/ 2026-07-30T08:28:00Z PULMONARY HYPERTENSION en Quality of Life Outcomes in Patients with Pulmonary Hypertension Receiving Prostacyclin Therapy: Impact of Anxiety, Depression, Sociodemographic Characteristics, and Treatment-Related Factors, Turkish Cardiology Journal, July 6, 2026 2026-07-30T08:26:50Z Blog https://ph-ksp.com/activin-signaling-inhibitors-in-pulmonary-hypertension-a-state-of-the-art-review-pulmonary-circulation-july-14-2026/ 2026-07-30T08:12:57Z PULMONARY HYPERTENSION en Activin Signaling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review via the Pulmonary Vascular Research Institute (PVRI), Pulmonary Circulation, July 14, 2026 2026-07-30T08:11:12Z Blog https://ph-ksp.com/historically-marginalized-and-minoritized-populations-with-pah-a-deeper-dive-into-a-complex-question-chest-july-14-2026/ 2026-07-30T04:59:22Z PULMONARY HYPERTENSION en Historically Marginalized And Minoritized Populations With Pulmonary Arterial Hypertension: A Deeper Dive Into a Complex Question, CHEST July 14, 2026 2026-07-30T04:58:13Z Blog https://ph-ksp.com/the-ethical-application-of-artificial-intelligence-in-digital-health-european-heart-journal-digital-health-volume-7-issue-6-july-2026/ 2026-07-30T04:32:40Z PULMONARY HYPERTENSION en The Ethical Application of Artificial Intelligence in Digital Health, European Heart Journal - Digital Health, Volume 7, Issue 6, July 2026 2026-07-30T04:29:38Z Blog https://ph-ksp.com/ralinepag-for-the-treatment-of-pulmonary-arterial-hypertension-advance-outcomes/ 2026-07-30T04:11:05Z PULMONARY HYPERTENSION en Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): findings from the phase 3 study, The Lancet, July 26, 2026 2026-07-30T04:08:39Z Blog